Creatine Is Cheap and Well-Studied, But the "Energy and Muscle" Pitch Needs Fine Print

Creatine monohydrate costs less than a euro a day and sits near the top of sports nutrition's evidence pile. The International Society of Sports Nutrition reviewed the compound in its 2017 position stand and concluded it raises intramuscular creatine stores, supports training adaptations, and shows no pattern of serious adverse events across the trials it covered, including supervised use in adolescents.

The mechanism explains why "energy boost" claims need a caveat. Creatine feeds the phosphocreatine system that regenerates ATP during short, intense efforts like a heavy squat or a sprint. It doesn't work like caffeine, which raises alertness through the nervous system. A lifter who takes creatine before a workout isn't getting a jolt. Their muscles get a faster way to resupply the energy that fuels the first few seconds of a hard set.

A meta-analysis published in Frontiers in Nutrition in 2026 reported significant gains in squat one-rep max and anaerobic power among supplement users, with one condition attached: the lifters were also doing resistance training. Creatine amplifies an existing training stimulus. It doesn't create one on its own.

That condition matters because of a competing result. A 2026 University of New South Wales trial found creatine performed no better than a placebo for muscle gain, according to secondary reporting on the study summarized by Pulse.bot. The trial reportedly skipped the loading phase, the short stretch of higher daily doses researchers use to saturate muscle creatine stores before switching to a maintenance dose. Skip that phase and the body takes weeks longer to reach the same saturation point. A short trial without a loading phase can miss effects that a longer one would catch.

Sex also shapes outcomes. A 2025 study covered by News-Medical found that a seven-day creatine "wash-in" period produced measurable lean-mass gains in women. Men in the same trial didn't show the same gains over that short window. A single headline claim of universal muscle building misses that split.

A separate 2026 trial at Texas A&M, reported through the Journal of the International Society of Sports Nutrition, suggested creatine may help preserve muscle even without resistance training, with secondary findings pointing to possible cognitive benefits. Those cognitive results are exploratory, not confirmed outcomes, and researchers flagged them as a direction for further study rather than a settled claim.

Access for minors has turned into a live fight inside the research community itself. A 2025 opinion article in Frontiers in Nutrition, authored by Richard Kreider and colleagues tied to the ISSN, argued against restricting creatine sales to young people. The authors cited the compound's FDA GRAS status and NHANES data linking low dietary creatine intake in children to slower growth and reduced muscle mass. The piece is an opinion, not a systematic review, and its authors work within the same research network that has long promoted creatine supplementation.

France's food-safety agency, ANSES, has taken a more cautious line on sports supplements broadly. A November 2016 ANSES opinion flagged creatine, alongside DHEA and whey or casein protein powders, among substances tied to reported cardiovascular and psychiatric adverse events collected during a 2009 to 2016 surveillance period. The agency's conclusion for some of these products: real risk, with benefit that remains unproven for the specific formulations on the market. ANSES also advises caution for children, teenagers, and pregnant or breastfeeding women, and recommends against stacking multiple supplements or combining them with medication.

Creatine has been on France's authorized supplement list since an arrêté dated September 26, 2016, with a cited daily dose cap of 3,000 milligrams, a figure worth checking against the current text on Legifrance before treating it as fixed. The price point holds up against pre-workout blends and protein powders on a cost-per-dose basis. What the shaker doesn't tell you is which study design, which training program, and which loading schedule the number on the label is supposed to match.